Global /South Korea /Healthcare /Drug Manufacturers - General /106190

High Tech Pharm Co., Ltd.

106190

• KRX: 106190 • Delayed

19,470KRW 0.8%

12.76 USD

As of 13 June 2026, High Tech Pharm Co., Ltd. has a market cap of $136.13M USD, ranking #23470 globally and #1034 in South Korea. It ranks #2105 in the Healthcare sector, and #759 in the Drug Manufacturers - General industry.

Global Rank

23470

Country Rank

1034

Sector Rank

2105

Industry Rank

759

Key Stats

Market Cap

$136.13MUSD

207.03B KRW

Enterprise Value

$126.22MUSD

192.63B KRW

Revenue (TTM)

$46.15MUSD

70.18B KRW

EBITDA (TTM)

$11.97MUSD

18.27B KRW

Net Income (TTM)

$7.55MUSD

11.48B KRW

EBITDA Margin

26%

Profit Margin

16%

PE Ratio

18.0

PS Ratio

2.9

PB Ratio

1.6

EV/EBITDA

10.5

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jeong-Soo Kim open_in_new

Employees

Founded

1998

Website

htpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	-3.7%	-23%	63%	45%	61%	48%	116%	59%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	106190 (주)하이텍팜 ISIN: KR7106190002 Shares Out.: Shares Outstanding: 10.633M¹ Shares Float: 5.819M² TV: TradingView: KRX: 106190 SA: Stock Analysis: KRX: 106190 YF: Yahoo Finance: 106190.KS GF: Google Finance: KRX: 106190 BA: Barron's: 106190 MS: Morningstar: XKRX: 106190	19,470 KRW	TV: TradingView: KRX: 106190 SA: Stock Analysis: KRX: 106190 YF: Yahoo Finance: 106190.KS GF: Google Finance: KRX: 106190 BA: Barron's: 106190 MS: Morningstar: XKRX: 106190

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About High Tech Pharm Co., Ltd.

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 7K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 5K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 559K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 402K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 265K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 236K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 212K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 202K%	20.5	Switzerland

chevron_leftBack